Led · Seed · Apr 2026

Protocole offers a clinical-grade peptide platform designed around standardized protocols, integrating physician oversight and pharmacy fulfillment. The company emphasizes safe, supervised, and consistent access to peptides, addressing fragmented and inconsistent prior approaches. Founders Delphine Le Grand and Cindy Yan launched the company with advisors including Dr. Poonam Desai, Nick Andrews, and Derek Flanzraich. Protocole is positioning itself as an infrastructure layer for the peptide category and plans to invest in research, standardization, and education. The company has begun hiring across multiple roles and recently raised a $6M seed round to support these efforts.